Clark Chen, MD, discusses where tile-based radiation therapy fits within the broader glioblastoma treatment regimen and where the approach may be headed next.
Clark Chen, MD, PhD
Advertisement
Clark Chen, MD, PhD, is director of the Brain Tumor Program and co-director of the Gamma Knife Stereotactic Radiosurgery Program at Brown University Health.
Articles by Clark Chen, MD, PhD
In the GESTALT feasibility and safety trial, GammaTile reduced rapid early progression to 6% vs a historical 50% to 80%, with 93% of patients starting chemoradiation on schedule.
Advertisement
Latest Updated Articles
Why Brain Cancer Treatment Feels Like a Rigged MarathonSeptember 2nd 2026
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Insurance Delays and Travel Strain CAR T Referral in Early Relapsed Myeloma
2
NCCN Guidelines Add Cosibelimab for Locally Advanced CSCC
3
Real-World Data for Darolutamide vs Abiraterone Triplet Therapy in mHSPC
4
Oncologists Debate Role of On-Body Injector for Transplant-Ineligible Myeloma
5